Pancreatic cystic lesions are an increasingly common clinical finding. They represent a
heterogeneous group of lesions that include two of the three known precursors of pancreatic …

Intraductal papillary mucinous neoplasms (IPMNs) represent approximately 1% of all
pancreatic neoplasms and 25% of cystic neoplasms. They are divided into three types: main …

Background & Aims Dilatation of the main pancreatic duct (MPD) has been a surgical
indication for intraductal papillary mucinous neoplasms (IPMNs). Few studies have …

Objectives Current guidelines base the management of intraductal papillary mucinous
neoplasms (IPMN) on several well-established resection criteria (RC), including cyst size …

BACKGROUND: The 2017 revised International Association of Pancreatology guidelines for
management of intraductal papillary mucinous neoplasm (IPMN) describe worrisome …

Background The consensus guidelines for branch-duct intraductal papillary mucinous
neoplasm (BD-IPMN) of the pancreas are mostly based on imaging features. This study …

Background This systematic review aimed to assess the diagnostic accuracy of the
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …

Pancreatic cancer is one of the most lethal cancers, largely related to the difficulties with
early detection, as it typically presents in later stages. Pancreatic cystic neoplasms (PCN) …

Purpose To investigate the common CT findings of high-grade (HG) PanIN and clinical
effects in the remnant pancreas in patients with intraductal papillary mucinous neoplasm …

The incidence of pancreatic cystic lesions (PCLs) has been rising due to improvements in
imaging. Of these, intraductal papillary mucinous neoplasms (IPMNs) are the most common …